Is AbbVie Inc halal to invest in?

As of July 2026, AbbVie Inc ABBV is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is AbbVie Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes AbbVie Inc using these criteria to determine its compliance status.

Can Muslims buy shares of AbbVie Inc?

Muslim investors may consider investing in AbbVie Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is AbbVie Inc classified as NOT HALAL?

Musaffa determines the Shariah status of AbbVie Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for AbbVie Inc updated?

The Shariah compliance status of AbbVie Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like AbbVie Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of AbbVie Inc?

You can check the latest Shariah compliance status of AbbVie Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

ABBV Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, AbbVie Inc is classified as not halal.

NOT HALAL

Report Source: 2026 1st Quarter Report

AbbVie Inc. Stock Analysis ABBV

United States Health Care Mega Cap Report: Q1, 2026

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Illinois and currently employs 57,000 full-time employees. The company went IPO on 2013-01-02. The company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Immunology products include rheumatology, dermatology and gastroenterology. Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere and Epkinly. Aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Eye Care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, and other eye care. Other key products include Mavyret/Maviret, Creon, and Linzess/Constella. Its investigational candidate, bretisilocin, is for the treatment of patients with moderate-to-severe major depressive disorder (MDD).

Key Statistics of AbbVie Inc (ABBV)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$252.25$257.81

Today's Open

$257.81

Volume

4.95M

P/E Ratio (TTM)

107.07

52 Week Range

$184.90$261.64

Market Cap

446.54B

Avg. Volume

9.05M

Dividend Yield

2.61%

Financial Metrics & Statements of AbbVie Inc (ABBV)

Super Investors Invested in AbbVie Inc (ABBV)

FAQ's for AbbVie Inc (ABBV)

As of July 2026, AbbVie Inc ABBV is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes AbbVie Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in AbbVie Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of AbbVie Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of AbbVie Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of AbbVie Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.